MED Medifast, Inc.
Stable Earnings Power
B- 62.5 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
B 70
  • 5yr Avg ROIC 39.6%
  • Operating Margin Trend -4.68 pp/yr

Capital Efficiency

Weight: 15%
A+ 94
  • 5yr Avg ROE 42.9%
  • 5yr Share-Count CAGR -1.5%

Growth Quality

Weight: 15%
F 12
  • 5yr Revenue CAGR -16.2%
  • Revenue-Growth Years (5) 2/5

Cash Generation

Weight: 15%
C+ 61
  • 5yr FCF Margin 6.3%
  • 5yr FCF/NI Conversion 2.79x

Balance Sheet

Weight: 20%
A+ 99
  • Net Debt / EBITDA -30.96x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 4.43

Stability

Weight: 15%
F 24
  • EPS Volatility (σ/μ) 0.80
  • Negative-Revenue Years (5) 3/5
  • Piotroski F-Score 3

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 new buy; 1 added.

Holders
2 +1
Avg Δ position
+27.0%
New buys
1
Full exits
0
As of Q2 2026